MENU
+Compare
APLIF
Stock ticker: OTC
AS OF
Dec 11 closing price
Price
$0.03
Change
-$0.00 (-0.00%)
Capitalization
3.41M

APLIF Appili Therapeutics Inc. Forecast, Technical & Fundamental Analysis

Industry Biotechnology
APLIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for APLIF with price predictions
Dec 17, 2024

Momentum Indicator for APLIF turns positive, indicating new upward trend

APLIF saw its Momentum Indicator move above the 0 level on December 12, 2024. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 116 similar instances where the indicator turned positive. In of the 116 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for APLIF just turned positive on December 06, 2024. Looking at past instances where APLIF's MACD turned positive, the stock continued to rise in of 48 cases over the following month. The odds of a continued upward trend are .

APLIF moved above its 50-day moving average on December 06, 2024 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for APLIF crossed bullishly above the 50-day moving average on December 03, 2024. This indicates that the trend has shifted higher and could be considered a buy signal. In of 26 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where APLIF advanced for three days, in of 143 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

APLIF broke above its upper Bollinger Band on November 26, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for APLIF entered a downward trend on December 03, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (14.664). P/E Ratio (0.000) is within average values for comparable stocks, (87.689). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.783). APLIF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (9.025) is also within normal values, averaging (260.687).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. APLIF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. APLIF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
APLIF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

APLIF is expected to report earnings to fall ∞% to 0 cents per share on June 27

Appili Therapeutics Inc. APLIF Stock Earnings Reports
Q1'24
Est.
$-0.01
Q4'23
Beat
by $0.01
The last earnings report on February 13 showed earnings per share of 0 cents, beating the estimate of 0 cents. With 171.80K shares outstanding, the current market capitalization sits at 3.41M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1344 Summer Street
Phone
+1 902 442-4655
Employees
9
Web
https://www.appilitherapeutics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RMYAX9.76-0.02
-0.20%
Russell Inv Multi-Strategy Income A
GAGIX31.73-0.15
-0.47%
Gabelli Global Rising Income and Div I
FOKFX26.68-0.18
-0.67%
Fidelity OTC K6
BMSSX14.50-0.16
-1.09%
MFS Blended Research Mid Cap Eq R2
JVMRX30.99-0.37
-1.18%
JHancock Disciplined Value Mid Cap R6

APLIF and Stocks

Correlation & Price change

A.I.dvisor tells us that APLIF and GENFF have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that APLIF and GENFF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APLIF
1D Price
Change %
APLIF100%
N/A
GENFF - APLIF
25%
Poorly correlated
N/A
CTCX - APLIF
21%
Poorly correlated
+6.09%
ARTH - APLIF
12%
Poorly correlated
+16.67%
ARGNF - APLIF
10%
Poorly correlated
N/A
AAVXF - APLIF
9%
Poorly correlated
N/A
More